Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,deferredLongTermAssetCharges,longTermInvestments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,otherCashflowsFromFinancingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,currency,shortName,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,marketState,exchangeDataDelayedBy,priceHint,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchange,market,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Jun 14, 2021) 4","Short Ratio (Jun 14, 2021) 4","Short % of Float (Jun 14, 2021) 4","Short % of Shares Outstanding (Jun 14, 2021) 4","Shares Short (prior month May 13, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry
t0,HOLX,-510400000.0,256232992,71500000,,780500000,600000,619900000,220400000,1152600000,786000000,786000000,,-21300000,,,,161100000,1537600000,751600000,385000000,-5500000,,619400000,619900000,1447600000.0,5927100000.0,4249000000.0,3794400000.0,212400000.0,8044000000.0,3000000.0,86500000.0,-298900000.0,503000000.0,2857200000.0,-1836800000.0,543200000.0,816400000.0,1036400000.0,85900000.0,-35800000.0,533600000.0,2662400000.0,1212300000.0,2686000000.0,456200000.0,225100000.0,,,45500000.0,-478200000.0,-19100000.0,-129200000.0,-126600000.0,10300000.0,-52300000.0,-120400000.0,2900000.0,552200000.0,95200000.0,-1900000.0,-24800000.0,4100000.0,-5600000.0,-34700000.0,,1626000000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,"Hologic, Inc.",0.12670822,20373086208,19.205315,5.36867,15,America/New_York,EDT,-14400000,False,False,PRE,0,2,79.51,1630526403,0.3600006,78.9,79.68,77.8903,1133651,NMS,us_market,0.45483336,77.8903 - 79.68,79.15,0.0,0.0,9,8,finmb_108544,NasdaqGS,"Hologic, Inc.",USD,2030287,1295600,22.7,0.39957753,56.81 - 85.0,-5.489998,-0.06458821,56.81,85.0,1619625660,1635850740,1636372800,10.918704,7.282,4.14,7.76,10.246134,14.81,74.866,4.644005,0.062030897,70.568405,8.941597,1.17,,,85.0,56.81,74.87,70.57,2.03M,1.3M,256.23M,,254.57M,0.59%,97.43%,5.92M,2.32,3.83%,2.31%,5.5M,,,,,,0.00%,,,2:1,"Apr 02, 2008","Sep 25, 2020","Mar 26, 2021",35.87%,47.33%,21.16%,64.65%,5.32B,20.51,103.40%,2.51B,2.89B,1.91B,7.28,543.70%,816.4M,3.19,2.8B,73.74,2.57,14.81,1.87B,1.38B,Value,01752,Healthcare,5814,10,6,"Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.",Marlborough,508 263 2900,MA,5,1609372800,1622505600,4,United States,http://www.hologic.com,86400,9,250 Campus Drive,Medical Instruments & Supplies
t-1,HOLX,-640200000.0,256232992,59300000,,832400000,1100000,654400000,219500000,1243000000,892500000,892500000,,-28100000,,,,179000000,1609800000,717300000,366800000,-60100000,,653400000,654400000,1244800000.0,5895300000.0,4281700000.0,3267900000.0,199800000.0,7550700000.0,3000000.0,30700000.0,-918800000.0,499800000.0,2663300000.0,-1711600000.0,531800000.0,868700000.0,1056000000.0,86000000.0,-30700000.0,514500000.0,2596300000.0,1216100000.0,2709100000.0,420200000.0,184300000.0,,,-5900000.0,-49900000.0,-290100000.0,-428200000.0,39800000.0,23300000.0,167700000.0,-147700000.0,-4200000.0,650000000.0,92800000.0,-200000.0,-21200000.0,-175500000.0,56700000.0,-44800000.0,-13700000.0,1540300000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,"Hologic, Inc.",0.12670822,20373086208,19.205315,5.36867,15,America/New_York,EDT,-14400000,False,False,PRE,0,2,79.51,1630526403,0.3600006,78.9,79.68,77.8903,1133651,NMS,us_market,0.45483336,77.8903 - 79.68,79.15,0.0,0.0,9,8,finmb_108544,NasdaqGS,"Hologic, Inc.",USD,2030287,1295600,22.7,0.39957753,56.81 - 85.0,-5.489998,-0.06458821,56.81,85.0,1619625660,1635850740,1636372800,10.918704,7.282,4.14,7.76,10.246134,14.81,74.866,4.644005,0.062030897,70.568405,8.941597,1.17,,,85.0,56.81,74.87,70.57,2.03M,1.3M,256.23M,,254.57M,0.59%,97.43%,5.92M,2.32,3.83%,2.31%,5.5M,,,,,,0.00%,,,2:1,"Apr 02, 2008","Sep 25, 2020","Mar 26, 2021",35.87%,47.33%,21.16%,64.65%,5.32B,20.51,103.40%,2.51B,2.89B,1.91B,7.28,543.70%,816.4M,3.19,2.8B,73.74,2.57,14.81,1.87B,1.38B,Value,01752,Healthcare,5814,10,6,"Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.",Marlborough,508 263 2900,MA,5,1609372800,1622505600,4,United States,http://www.hologic.com,86400,9,250 Campus Drive,Medical Instruments & Supplies
t-2,HOLX,-1260200000.0,256232992,57000000,,617100000,2100000,494900000,224200000,1002400000,650100000,650100000,-2900000.0,-25000000,,,,123500000,1346900000,696800000,344500000,-33000000,,493600000,494900000,1307500000.0,5904800000.0,4488500000.0,2705200000.0,311400000.0,7195800000.0,2900000.0,50000000.0,-1573200000.0,429300000.0,2657900000.0,-1629300000.0,424500000.0,701000000.0,1239300000.0,324900000.0,-49700000.0,572200000.0,2222300000.0,1028900000.0,2736900000.0,395100000.0,178800000.0,15500000.0,11400000.0,59700000.0,-137900000.0,-259900000.0,-350900000.0,59300000.0,10900000.0,-43200000.0,-101900000.0,3600000.0,442000000.0,94300000.0,-200000.0,22700000.0,-296600000.0,900000.0,-58300000.0,-13700000.0,983000000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,"Hologic, Inc.",0.12670822,20373086208,19.205315,5.36867,15,America/New_York,EDT,-14400000,False,False,PRE,0,2,79.51,1630526403,0.3600006,78.9,79.68,77.8903,1133651,NMS,us_market,0.45483336,77.8903 - 79.68,79.15,0.0,0.0,9,8,finmb_108544,NasdaqGS,"Hologic, Inc.",USD,2030287,1295600,22.7,0.39957753,56.81 - 85.0,-5.489998,-0.06458821,56.81,85.0,1619625660,1635850740,1636372800,10.918704,7.282,4.14,7.76,10.246134,14.81,74.866,4.644005,0.062030897,70.568405,8.941597,1.17,,,85.0,56.81,74.87,70.57,2.03M,1.3M,256.23M,,254.57M,0.59%,97.43%,5.92M,2.32,3.83%,2.31%,5.5M,,,,,,0.00%,,,2:1,"Apr 02, 2008","Sep 25, 2020","Mar 26, 2021",35.87%,47.33%,21.16%,64.65%,5.32B,20.51,103.40%,2.51B,2.89B,1.91B,7.28,543.70%,816.4M,3.19,2.8B,73.74,2.57,14.81,1.87B,1.38B,Value,01752,Healthcare,5814,10,6,"Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.",Marlborough,508 263 2900,MA,5,1609372800,1622505600,4,United States,http://www.hologic.com,86400,9,250 Campus Drive,Medical Instruments & Supplies
t-3,HOLX,-1590300000.0,256232992,55100000,,168400000,3500000,137900000,208800000,529000000,192000000,192000000,-2900000.0,-27400000,,,,32000000,822900000,630900000,293900000,-23600000,,136400000,137900000,1252500000.0,5861700000.0,4544500000.0,2255100000.0,186100000.0,6803100000.0,2900000.0,45800000.0,-2068100000.0,357700000.0,2592900000.0,-1541400000.0,435700000.0,744200000.0,1345700000.0,570900000.0,-61900000.0,539200000.0,1982800000.0,728000000.0,2754900000.0,413600000.0,127300000.0,,,-7500000.0,-36300000.0,-259700000.0,-241700000.0,118900000.0,18100000.0,-55600000.0,-101900000.0,-600000.0,223000000.0,93600000.0,-1300000.0,-14700000.0,-130200000.0,8000000.0,-35000000.0,-100000.0,637100000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,"Hologic, Inc.",0.12670822,20373086208,19.205315,5.36867,15,America/New_York,EDT,-14400000,False,False,PRE,0,2,79.51,1630526403,0.3600006,78.9,79.68,77.8903,1133651,NMS,us_market,0.45483336,77.8903 - 79.68,79.15,0.0,0.0,9,8,finmb_108544,NasdaqGS,"Hologic, Inc.",USD,2030287,1295600,22.7,0.39957753,56.81 - 85.0,-5.489998,-0.06458821,56.81,85.0,1619625660,1635850740,1636372800,10.918704,7.282,4.14,7.76,10.246134,14.81,74.866,4.644005,0.062030897,70.568405,8.941597,1.17,,,85.0,56.81,74.87,70.57,2.03M,1.3M,256.23M,,254.57M,0.59%,97.43%,5.92M,2.32,3.83%,2.31%,5.5M,,,,,,0.00%,,,2:1,"Apr 02, 2008","Sep 25, 2020","Mar 26, 2021",35.87%,47.33%,21.16%,64.65%,5.32B,20.51,103.40%,2.51B,2.89B,1.91B,7.28,543.70%,816.4M,3.19,2.8B,73.74,2.57,14.81,1.87B,1.38B,Value,01752,Healthcare,5814,10,6,"Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.",Marlborough,508 263 2900,MA,5,1609372800,1622505600,4,United States,http://www.hologic.com,86400,9,250 Campus Drive,Medical Instruments & Supplies
